An Invariant Protein That Colocalizes With VAR2CSA on Plasmodium falciparum-Infected Red Cells Binds to Chondroitin Sulfate A

Gladys J Keitany,Bethany J Jenkins,Harold T Obiakor,Shaji Daniel,Atis Muehlenbachs,Jean-Philippe Semblat,Benoit Gamain,Justin Y A Doritchamou,Sanjay A Desai,Nicholas J MacDonald,David L Narum,Robert Morrison,Tracy Saveria,Marissa Vignali,Andrew V Oleinikov,Michal Fried,Patrick E Duffy

DOI: https://doi.org/10.1093/infdis/jiab550

2022-06-01

Abstract:Background: Plasmodium falciparum-infected red blood cells (iRBCs) bind and sequester in deep vascular beds, causing malaria-related disease and death. In pregnant women, VAR2CSA binds to chondroitin sulfate A (CSA) and mediates placental sequestration, making it the major placental malaria (PM) vaccine target. Methods: In this study, we characterize an invariant protein associated with PM called P falciparum chondroitin sulfate A ligand (PfCSA-L). Results: Recombinant PfCSA-L binds both placental CSA and VAR2CSA with nanomolar affinity, and it is coexpressed on the iRBC surface with VAR2CSA. Unlike VAR2CSA, which is anchored by a transmembrane domain, PfCSA-L is peripherally associated with the outer surface of knobs through high-affinity protein-protein interactions with VAR2CSA. This suggests that iRBC sequestration involves complexes of invariant and variant surface proteins, allowing parasites to maintain both diversity and function at the iRBC surface. Conclusions: The PfCSA-L is a promising target for intervention because it is well conserved, exposed on infected cells, and expressed and localized with VAR2CSA.